XML 59 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Financial Instruments - Information About Changes in Liabilities for Contingent Consideration (Details)
$ in Millions
3 Months Ended
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value, beginning balance $ 456 $ 777
Changes in estimated fair value 14 (84)
Payments (117) (119)
Other 0 (2)
Fair value, ending balance 353 572
Contingent consideration 353 $ 572
Current liability 127  
Sanofi Pasteur    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value, ending balance 263  
Contingent consideration $ 263  
Contingent consideration, measurement input, discount rate 0.115